MedPath

Preventive Cognitive Therapy with Neurocognitive Remediation Therapy for partially remitted depressed patients: a pragmatic randomized controlled multicentre trial.

Conditions
Major Depressive Disorder
Registration Number
NL-OMON22498
Lead Sponsor
Amsterdam UMC, location AMC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
115
Inclusion Criteria

Does not meet the criteria of a current MDD episode according to the DSM-5, as assessed with the Structured Clinical Interview for DSM-5 disorders (SCID-5-S; First et al., 2016);
- Is more than 8 weeks MDD diagnosis-free (with a maximum of 2 years);
- Has a Hamilton Depression Interview (HAM-D) score of =8 and =15 (Hamilton, 1980);
- Is aged 18 or older;
- Speaks Dutch or English.

Exclusion Criteria

- Current (hypo)mania or a history of bipolar illness;
- Any psychotic disorder;
- Alcohol or drug misuse;
- Primary Anxiety disorder diagnosis;
- Electroconvulsive therapy in the previous 12 months;
- Neurological disorder;
- Disabling sensory and/or motor deficit.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depressive symptoms over a one-year period: this main study parameter will be assessed monthly during a one-year period after baseline assessment using the Inventory of Depressive Symptomatology (IDS-SR).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath